Epidemiologic and molecular prognostic review of glioblastoma

Jigisha P. Thakkar, Therese A. Dolecek, Craig Horbinski, Quinn T. Ostrom, Donita D. Lightner, Jill S. Barnholtz-Sloan, John L. Villano

Research output: Contribution to journalReview articlepeer-review

875 Scopus citations


Glioblastoma multiforme (GBM) is the most common and aggressive primary central nervous system malignancy with a median survival of 15 months. The average incidence rate of GBM is 3.19/100,000 population, and the median age of diagnosis is 64 years. Incidence is higher in men and individuals of white race and non-Hispanic ethnicity. Many genetic and environmental factors have been studied in GBM, but the majority are sporadic, and no risk factor accounting for a large proportion of GBMs has been identified. However, several favorable clinical prognostic factors are identified, including younger age at diagnosis, cerebellar location, high performance status, and maximal tumor resection. GBMs comprise of primary and secondary subtypes, which evolve through different genetic pathways, affect patients at different ages, and have differences in outcomes. We report the current epidemiology of GBM with new data from the Central Brain Tumor Registry of the United States 2006 to 2010 as well as demonstrate and discuss trends in incidence and survival. We also provide a concise review on molecular markers in GBM that have helped distinguish biologically similar subtypes of GBM and have prognostic and predictive value.

Original languageEnglish
Pages (from-to)1985-1996
Number of pages12
JournalCancer Epidemiology Biomarkers and Prevention
Issue number10
StatePublished - Oct 1 2014

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Epidemiologic and molecular prognostic review of glioblastoma'. Together they form a unique fingerprint.

Cite this